drugset / Trial / NCT02103725

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

NCT02103725

Phase 1 Completed 30 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to validate a left-right design with respect to detecting a difference in efficacy after 3 weeks of treatment between an active treatment and a vehicle in adults with mild to moderate atopic dermatitis

Timeline

Start
2014-04
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimecrolimus Small molecule

Indications